Renoprotection Provided by Losartan in Combination with Pioglitazone Is Superior to Renoprotection Provided by Losartan Alone in Patients with Type 2 Diabetic Nephropathy

Publisher： Karger

E-ISSN： 1423-0143|30|4|203-211

ISSN： 1420-4096

Source： Kidney and Blood Pressure Research, Vol.30, Iss.4, 2007-06, pp. : 203-211

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Magnoline on P-Selectin's Expression in Diabetic Rats and its Reno-Protection

By  

Kidney and Blood Pressure Research, Vol. 37, Iss. 2-3, 2013-05 ,pp. : 211-220

Karger

Access to resources Recommend Favorite

Enhanced Effect of Combined Treatment with SMP-534 (Antifibrotic Agent) and Losartan in Diabetic Nephropathy

By  

American Journal of Nephrology, Vol. 26, Iss. 1, 2006-04 ,pp. : 50-58

Karger

Access to resources Recommend Favorite

Urinary Copper Excretion in Type 2 Diabetic Patients with Nephropathy

By  

Nephron, Vol. 88, Iss. 4, 2001-07 ,pp. : 307-312

Karger

Access to resources Recommend Favorite

Effects of Combination Treatment with Losartan and Trandolapril on Office and Ambulatory Blood Pressures in Non-Diabetic Renal Disease: A COOPERATE-ABP Substudy

By  

American Journal of Nephrology, Vol. 24, Iss. 5, 2004-12 ,pp. : 543-548

Karger

Access to resources Recommend Favorite

Efficacy and Safety of Losartan in Patients with Proteinuria

By  

Nephron, Vol. 91, Iss. 3, 2002-07 ,pp. : 496-498

Karger

Access to resources Recommend Favorite